The trading price of Kazia Therapeutics Limited ADR (NASDAQ:KZIA) during today’s trading, the S&P 500 Index has current market day and closing at $9.05, 32.59% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $8.33 and $10.7899. In examining the 52-week price action we see that the stock hit a 52-week high of $79.00 and a 52-week low of $2.86. Over the past month, the stock has gained 60.17% in value.
Kazia Therapeutics Limited ADR, whose market valuation is $8.78 million at the time of this writing, is expected to release its quarterly earnings report in August. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest KZIA has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a Hold, while an average of long term indicators suggests that the stock is currently Hold.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned KZIA a recommendation rating is 1. Out of them, 0 rate it a Hold, while 1 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Kazia Therapeutics Limited ADR (KZIA) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that KZIA’s price is currently 19.61% off the SMA20 and 69.42% off the SMA50. The RSI metric on the 14-day chart is currently showing 67.68, and weekly volatility stands at 12.37%. When measured over the past 30 days, the indicator reaches 14.72%. Kazia Therapeutics Limited ADR (NASDAQ:KZIA)’s beta value is currently sitting at 2.62.
To see how Kazia Therapeutics Limited ADR stock has been performing today in comparison to its peers in the industry, here are the numbers: KZIA stock’s performance was 32.59% at last check in today’s session, and 2.26% in the past year.
An evaluation of the daily trading volume of Kazia Therapeutics Limited ADR (NASDAQ:KZIA) indicates that the 3-month average is 895.52K. However, this figure has increased over the past 10 days to an average of 0.12.
Currently, records show that 0.97 million of the company’s shares remain outstanding. The institutions hold 11.53%. The stats also highlight that short interest as of 2025-06-13, stood at 0.2 million shares, resulting in a short ratio of 0.09 at that time. From this, we can conclude that short interest is 1461.00 of the company’s total outstanding shares. It is noteworthy that short shares in June were up slightly from the previous month’s figure, which was 19992.0. However, since the stock’s price has seen -9.77% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
